175 related articles for article (PubMed ID: 20034865)
1. [Mouse models of K-ras-initiated oncogenesis].
Barrière C; Marjou FE; Louvard D; Robine S
Bull Cancer; 2009 Dec; 96 Suppl():S5-14. PubMed ID: 20034865
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of K-ras-initiated carcinogenesis.
Janssen KP; Abal M; El Marjou F; Louvard D; Robine S
Biochim Biophys Acta; 2005 Nov; 1756(2):145-54. PubMed ID: 16126346
[TBL] [Abstract][Full Text] [Related]
3. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Fisher GH; Wellen SL; Klimstra D; Lenczowski JM; Tichelaar JW; Lizak MJ; Whitsett JA; Koretsky A; Varmus HE
Genes Dev; 2001 Dec; 15(24):3249-62. PubMed ID: 11751631
[TBL] [Abstract][Full Text] [Related]
4. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
[TBL] [Abstract][Full Text] [Related]
5. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
6. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
[TBL] [Abstract][Full Text] [Related]
7. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
8. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
9. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
10. Mouse models for human lung cancer.
Meuwissen R; Berns A
Genes Dev; 2005 Mar; 19(6):643-64. PubMed ID: 15769940
[TBL] [Abstract][Full Text] [Related]
11. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
12. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
13. K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas.
James RM; Arends MJ; Plowman SJ; Brooks DG; Miles CG; West JD; Patek CE
Mol Cancer Res; 2003 Sep; 1(11):820-5. PubMed ID: 14517344
[TBL] [Abstract][Full Text] [Related]
14. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
Aoki K; Yoshida T; Sugimura T; Terada M
Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
16. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
17. Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.
Vitale-Cross L; Amornphimoltham P; Fisher G; Molinolo AA; Gutkind JS
Cancer Res; 2004 Dec; 64(24):8804-7. PubMed ID: 15604235
[TBL] [Abstract][Full Text] [Related]
18. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.
Jackson EL; Willis N; Mercer K; Bronson RT; Crowley D; Montoya R; Jacks T; Tuveson DA
Genes Dev; 2001 Dec; 15(24):3243-8. PubMed ID: 11751630
[TBL] [Abstract][Full Text] [Related]
19. EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Jiang K; Delarue FL; Sebti SM
Oncogene; 2004 Feb; 23(5):1136-45. PubMed ID: 14647415
[TBL] [Abstract][Full Text] [Related]
20. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
